Intelligent Bio Solutions & Quantum TM: Revolutionizing Fingerprint Drug Testing in the UK
Generado por agente de IAMarcus Lee
miércoles, 29 de enero de 2025, 8:38 am ET1 min de lectura
INBS--

Intelligent Bio Solutions (INBS), a leading medical technology company, has partnered with UK-based Quantum TM to expand the accessibility and scalability of fingerprint drug testing across the country. This collaboration will see the implementation of INBS' innovative, non-invasive drug screening technology at 10 Quantum TM sites, further enhancing workplace safety and productivity.
Quantum TM, a prominent provider of drug and alcohol testing services, has adopted INBS' fingerprint drug testing solution to offer its clients a more efficient and hygienic alternative to traditional testing methods. The partnership will enable Quantum TM to provide its customers with a faster, more cost-effective drug screening solution, minimizing downtime and improving overall safety.
Intelligent Bio Solutions' fingerprint drug testing technology offers numerous advantages over traditional methods, including:
1. Non-invasive and hygienic: The process is straightforward and hygienic, requiring only a fingerprint touch, respecting individual privacy and dignity.
2. Rapid results: The testing process provides quick results, allowing for immediate decision-making, which is crucial in industries where safety is paramount.
3. High sensitivity and specificity: The technology is designed to detect minute concentrations of drug metabolites, ensuring accurate results with high specificity, reducing the likelihood of false positives.
4. Addressing common questions: Fingerprint drug testing is effective at detecting recent drug use, typically within the past 16 to 24 hours, and can detect a range of commonly misused substances, including opioids, cocaine, cannabis, amphetamines, and benzodiazepines.
The partnership between Intelligent Bio Solutions and Quantum TM contributes to the broader adoption of fingerprint drug testing in the workplace, with implications for other industries. By expanding the customer base, validating the technology, and demonstrating its potential for other industries, this collaboration paves the way for increased acceptance and implementation of fingerprint drug testing solutions across various sectors. This ultimately enhances workplace safety and productivity, making it a more viable and attractive option for businesses and organizations seeking efficient, non-invasive drug testing solutions.
In conclusion, the collaboration between Intelligent Bio Solutions and Quantum TM represents a significant step forward in the adoption of fingerprint drug testing in the UK. By combining INBS' innovative technology with Quantum TM's extensive distribution network and expertise in drug and alcohol testing, this partnership offers a more accessible, scalable, and efficient drug screening solution for businesses and organizations across various industries.
QMCO--

Intelligent Bio Solutions (INBS), a leading medical technology company, has partnered with UK-based Quantum TM to expand the accessibility and scalability of fingerprint drug testing across the country. This collaboration will see the implementation of INBS' innovative, non-invasive drug screening technology at 10 Quantum TM sites, further enhancing workplace safety and productivity.
Quantum TM, a prominent provider of drug and alcohol testing services, has adopted INBS' fingerprint drug testing solution to offer its clients a more efficient and hygienic alternative to traditional testing methods. The partnership will enable Quantum TM to provide its customers with a faster, more cost-effective drug screening solution, minimizing downtime and improving overall safety.
Intelligent Bio Solutions' fingerprint drug testing technology offers numerous advantages over traditional methods, including:
1. Non-invasive and hygienic: The process is straightforward and hygienic, requiring only a fingerprint touch, respecting individual privacy and dignity.
2. Rapid results: The testing process provides quick results, allowing for immediate decision-making, which is crucial in industries where safety is paramount.
3. High sensitivity and specificity: The technology is designed to detect minute concentrations of drug metabolites, ensuring accurate results with high specificity, reducing the likelihood of false positives.
4. Addressing common questions: Fingerprint drug testing is effective at detecting recent drug use, typically within the past 16 to 24 hours, and can detect a range of commonly misused substances, including opioids, cocaine, cannabis, amphetamines, and benzodiazepines.
The partnership between Intelligent Bio Solutions and Quantum TM contributes to the broader adoption of fingerprint drug testing in the workplace, with implications for other industries. By expanding the customer base, validating the technology, and demonstrating its potential for other industries, this collaboration paves the way for increased acceptance and implementation of fingerprint drug testing solutions across various sectors. This ultimately enhances workplace safety and productivity, making it a more viable and attractive option for businesses and organizations seeking efficient, non-invasive drug testing solutions.
In conclusion, the collaboration between Intelligent Bio Solutions and Quantum TM represents a significant step forward in the adoption of fingerprint drug testing in the UK. By combining INBS' innovative technology with Quantum TM's extensive distribution network and expertise in drug and alcohol testing, this partnership offers a more accessible, scalable, and efficient drug screening solution for businesses and organizations across various industries.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios